{"transactions":[{"id":2375326,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-24T22:18:06.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":2598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":12989,"derivative":{"underlying":"Common Stock","underlying_shares":2598},"source":{"system":"sec-edgar","filing":"0001162194-22-000017","document":"wf-form4_164574106408439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000017/wf-form4_164574106408439.xml","form_type":"4"}},{"id":2375325,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-24T22:18:06.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":2391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":19126,"derivative":{"underlying":"Common Stock","underlying_shares":2391},"source":{"system":"sec-edgar","filing":"0001162194-22-000017","document":"wf-form4_164574106408439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000017/wf-form4_164574106408439.xml","form_type":"4"}},{"id":2375324,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-24T22:18:06.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":1531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":7657,"derivative":{"underlying":"Common Stock","underlying_shares":1531},"source":{"system":"sec-edgar","filing":"0001162194-22-000017","document":"wf-form4_164574106408439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000017/wf-form4_164574106408439.xml","form_type":"4"}},{"id":2375323,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-24T22:18:06.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":3740,"price":3.62,"value":13538.8,"ownership":{"direct":true},"balance_after":65103,"source":{"system":"sec-edgar","filing":"0001162194-22-000017","document":"wf-form4_164574106408439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000017/wf-form4_164574106408439.xml","form_type":"4"}},{"id":2375322,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-24T22:18:06.000Z","date":"2022-02-22","kind":"exercise","acquired":true,"shares":2598,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":68843,"source":{"system":"sec-edgar","filing":"0001162194-22-000017","document":"wf-form4_164574106408439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000017/wf-form4_164574106408439.xml","form_type":"4"}},{"id":2375321,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-24T22:18:06.000Z","date":"2022-02-22","kind":"exercise","acquired":true,"shares":2391,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":66245,"source":{"system":"sec-edgar","filing":"0001162194-22-000017","document":"wf-form4_164574106408439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000017/wf-form4_164574106408439.xml","form_type":"4"}},{"id":2375320,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-24T22:18:06.000Z","date":"2022-02-22","kind":"exercise","acquired":true,"shares":1531,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63854,"source":{"system":"sec-edgar","filing":"0001162194-22-000017","document":"wf-form4_164574106408439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000017/wf-form4_164574106408439.xml","form_type":"4"}},{"id":2426925,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-26T00:37:54.000Z","date":"2022-01-23","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without \"cause.\""},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without \"cause.\""}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001162194-22-000008","document":"wf-form4_164315745888368.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000008/wf-form4_164315745888368.xml","form_type":"4"}},{"id":2496184,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-11-24T23:45:53.000Z","date":"2021-11-20","kind":"exercise","acquired":false,"shares":2390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":21517,"derivative":{"underlying":"Common Stock","underlying_shares":2390},"source":{"system":"sec-edgar","filing":"0001162194-21-000097","document":"wf-form4_163779753920021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000097/wf-form4_163779753920021.xml","form_type":"4"}},{"id":2496183,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-11-24T23:45:53.000Z","date":"2021-11-20","kind":"exercise","acquired":false,"shares":1531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":9188,"derivative":{"underlying":"Common Stock","underlying_shares":1531},"source":{"system":"sec-edgar","filing":"0001162194-21-000097","document":"wf-form4_163779753920021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000097/wf-form4_163779753920021.xml","form_type":"4"}},{"id":2496182,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-11-24T23:45:53.000Z","date":"2021-11-20","kind":"exercise","acquired":false,"shares":2598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":15587,"derivative":{"underlying":"Common Stock","underlying_shares":2598},"source":{"system":"sec-edgar","filing":"0001162194-21-000097","document":"wf-form4_163779753920021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000097/wf-form4_163779753920021.xml","form_type":"4"}},{"id":2496181,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-24T23:45:53.000Z","date":"2021-11-20","kind":"tax_withholding","acquired":false,"shares":3530,"price":4.49,"value":15849.7,"ownership":{"direct":true},"balance_after":62323,"source":{"system":"sec-edgar","filing":"0001162194-21-000097","document":"wf-form4_163779753920021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000097/wf-form4_163779753920021.xml","form_type":"4"}},{"id":2496180,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-24T23:45:53.000Z","date":"2021-11-20","kind":"exercise","acquired":true,"shares":2390,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":65853,"source":{"system":"sec-edgar","filing":"0001162194-21-000097","document":"wf-form4_163779753920021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000097/wf-form4_163779753920021.xml","form_type":"4"}},{"id":2496179,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-24T23:45:53.000Z","date":"2021-11-20","kind":"exercise","acquired":true,"shares":1531,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63463,"source":{"system":"sec-edgar","filing":"0001162194-21-000097","document":"wf-form4_163779753920021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000097/wf-form4_163779753920021.xml","form_type":"4"}},{"id":2496178,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-24T23:45:53.000Z","date":"2021-11-20","kind":"exercise","acquired":true,"shares":2598,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61932,"source":{"system":"sec-edgar","filing":"0001162194-21-000097","document":"wf-form4_163779753920021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000097/wf-form4_163779753920021.xml","form_type":"4"}},{"id":2592656,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-08-24T23:11:08.000Z","date":"2021-08-20","kind":"exercise","acquired":false,"shares":2391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":23907,"derivative":{"underlying":"Common Stock","underlying_shares":2391},"source":{"system":"sec-edgar","filing":"0001162194-21-000082","document":"wf-form4_162984664031679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000082/wf-form4_162984664031679.xml","form_type":"4"}},{"id":2592655,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-08-24T23:11:08.000Z","date":"2021-08-20","kind":"exercise","acquired":false,"shares":1531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":10719,"derivative":{"underlying":"Common Stock","underlying_shares":1531},"source":{"system":"sec-edgar","filing":"0001162194-21-000082","document":"wf-form4_162984664031679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000082/wf-form4_162984664031679.xml","form_type":"4"}},{"id":2592654,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-08-24T23:11:08.000Z","date":"2021-08-20","kind":"exercise","acquired":false,"shares":2597,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":18185,"derivative":{"underlying":"Common Stock","underlying_shares":2597},"source":{"system":"sec-edgar","filing":"0001162194-21-000082","document":"wf-form4_162984664031679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000082/wf-form4_162984664031679.xml","form_type":"4"}},{"id":2592653,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T23:11:08.000Z","date":"2021-08-20","kind":"tax_withholding","acquired":false,"shares":3523,"price":6.53,"value":23005.19,"ownership":{"direct":true},"balance_after":59334,"source":{"system":"sec-edgar","filing":"0001162194-21-000082","document":"wf-form4_162984664031679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000082/wf-form4_162984664031679.xml","form_type":"4"}},{"id":2592652,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T23:11:08.000Z","date":"2021-08-20","kind":"exercise","acquired":true,"shares":2391,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62857,"source":{"system":"sec-edgar","filing":"0001162194-21-000082","document":"wf-form4_162984664031679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000082/wf-form4_162984664031679.xml","form_type":"4"}},{"id":2592651,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T23:11:08.000Z","date":"2021-08-20","kind":"exercise","acquired":true,"shares":1531,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60466,"source":{"system":"sec-edgar","filing":"0001162194-21-000082","document":"wf-form4_162984664031679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000082/wf-form4_162984664031679.xml","form_type":"4"}},{"id":2592650,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T23:11:08.000Z","date":"2021-08-20","kind":"exercise","acquired":true,"shares":2597,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":58935,"source":{"system":"sec-edgar","filing":"0001162194-21-000082","document":"wf-form4_162984664031679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000082/wf-form4_162984664031679.xml","form_type":"4"}},{"id":2699294,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-05-24T20:08:16.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On May 23, 2020, the Reporting Person was granted 120,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On May 23, 2020, the Reporting Person was granted 120,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023."}],"balance_after":60000,"derivative":{"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001162194-21-000042","document":"wf-form4_162188687090616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000042/wf-form4_162188687090616.xml","form_type":"4"}},{"id":2699293,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-05-24T20:08:16.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":2390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":26298,"derivative":{"underlying":"Common Stock","underlying_shares":2390},"source":{"system":"sec-edgar","filing":"0001162194-21-000042","document":"wf-form4_162188687090616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000042/wf-form4_162188687090616.xml","form_type":"4"}},{"id":2699292,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-05-24T20:08:16.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":1532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":12250,"derivative":{"underlying":"Common Stock","underlying_shares":1532},"source":{"system":"sec-edgar","filing":"0001162194-21-000042","document":"wf-form4_162188687090616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000042/wf-form4_162188687090616.xml","form_type":"4"}},{"id":2699291,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-05-24T20:08:16.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":2598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":20782,"derivative":{"underlying":"Common Stock","underlying_shares":2598},"source":{"system":"sec-edgar","filing":"0001162194-21-000042","document":"wf-form4_162188687090616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000042/wf-form4_162188687090616.xml","form_type":"4"}},{"id":2699290,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-05-24T20:08:16.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":36087,"price":5.52,"value":199200.24,"ownership":{"direct":true},"balance_after":56338,"source":{"system":"sec-edgar","filing":"0001162194-21-000042","document":"wf-form4_162188687090616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000042/wf-form4_162188687090616.xml","form_type":"4"}},{"id":2699289,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-05-24T20:08:16.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":92425,"source":{"system":"sec-edgar","filing":"0001162194-21-000042","document":"wf-form4_162188687090616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000042/wf-form4_162188687090616.xml","form_type":"4"}},{"id":2699288,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-05-24T20:08:16.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":2390,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32425,"source":{"system":"sec-edgar","filing":"0001162194-21-000042","document":"wf-form4_162188687090616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000042/wf-form4_162188687090616.xml","form_type":"4"}},{"id":2699287,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-05-24T20:08:16.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":1532,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30035,"source":{"system":"sec-edgar","filing":"0001162194-21-000042","document":"wf-form4_162188687090616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000042/wf-form4_162188687090616.xml","form_type":"4"}},{"id":2699286,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-05-24T20:08:16.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":2598,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28503,"source":{"system":"sec-edgar","filing":"0001162194-21-000042","document":"wf-form4_162188687090616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000042/wf-form4_162188687090616.xml","form_type":"4"}},{"id":2742168,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-04-22T22:31:50.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":65792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vest as to 1/4 of the underlying shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vest as to 1/4 of the underlying shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter."}],"balance_after":65792,"derivative":{"underlying":"Common Stock","underlying_shares":65792},"source":{"system":"sec-edgar","filing":"0001162194-21-000032","document":"wf-form4_161913069571662.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000032/wf-form4_161913069571662.xml","form_type":"4"}},{"id":2839861,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-24T02:57:34.000Z","date":"2021-02-20","kind":"exercise","acquired":false,"shares":9562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":28688,"derivative":{"underlying":"Common Stock","underlying_shares":9562},"source":{"system":"sec-edgar","filing":"0001162194-21-000007","document":"wf-form4_161413543384058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000007/wf-form4_161413543384058.xml","form_type":"4"}},{"id":2839860,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-24T02:57:34.000Z","date":"2021-02-20","kind":"exercise","acquired":false,"shares":1531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":13782,"derivative":{"underlying":"Common Stock","underlying_shares":1531},"source":{"system":"sec-edgar","filing":"0001162194-21-000007","document":"wf-form4_161413543384058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000007/wf-form4_161413543384058.xml","form_type":"4"}},{"id":2839859,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-24T02:57:34.000Z","date":"2021-02-20","kind":"exercise","acquired":false,"shares":2598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":23380,"derivative":{"underlying":"Common Stock","underlying_shares":2598},"source":{"system":"sec-edgar","filing":"0001162194-21-000007","document":"wf-form4_161413543384058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000007/wf-form4_161413543384058.xml","form_type":"4"}},{"id":2839858,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-24T02:57:34.000Z","date":"2021-02-20","kind":"tax_withholding","acquired":false,"shares":7872,"price":6.12,"value":48176.64,"ownership":{"direct":true},"balance_after":25905,"source":{"system":"sec-edgar","filing":"0001162194-21-000007","document":"wf-form4_161413543384058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000007/wf-form4_161413543384058.xml","form_type":"4"}},{"id":2839857,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-24T02:57:34.000Z","date":"2021-02-20","kind":"exercise","acquired":true,"shares":9562,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33777,"source":{"system":"sec-edgar","filing":"0001162194-21-000007","document":"wf-form4_161413543384058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000007/wf-form4_161413543384058.xml","form_type":"4"}},{"id":2839856,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-24T02:57:34.000Z","date":"2021-02-20","kind":"exercise","acquired":true,"shares":1531,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24215,"source":{"system":"sec-edgar","filing":"0001162194-21-000007","document":"wf-form4_161413543384058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000007/wf-form4_161413543384058.xml","form_type":"4"}},{"id":2839855,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-24T02:57:34.000Z","date":"2021-02-20","kind":"exercise","acquired":true,"shares":2598,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22684,"source":{"system":"sec-edgar","filing":"0001162194-21-000007","document":"wf-form4_161413543384058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000007/wf-form4_161413543384058.xml","form_type":"4"}},{"id":2968432,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-11-24T22:21:51.000Z","date":"2020-11-20","kind":"exercise","acquired":false,"shares":1531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":15313,"derivative":{"underlying":"Common Stock","underlying_shares":1531},"source":{"system":"sec-edgar","filing":"0001162194-20-000112","document":"wf-form4_160625649736161.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000112/wf-form4_160625649736161.xml","form_type":"4"}},{"id":2968431,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-11-24T22:21:51.000Z","date":"2020-11-20","kind":"exercise","acquired":false,"shares":2598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":25978,"derivative":{"underlying":"Common Stock","underlying_shares":2598},"source":{"system":"sec-edgar","filing":"0001162194-20-000112","document":"wf-form4_160625649736161.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000112/wf-form4_160625649736161.xml","form_type":"4"}},{"id":2968430,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-11-24T22:21:51.000Z","date":"2020-11-20","kind":"tax_withholding","acquired":false,"shares":1699,"price":6.28,"value":10669.72,"ownership":{"direct":true},"balance_after":20086,"source":{"system":"sec-edgar","filing":"0001162194-20-000112","document":"wf-form4_160625649736161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000112/wf-form4_160625649736161.xml","form_type":"4"}},{"id":2968429,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-11-24T22:21:51.000Z","date":"2020-11-20","kind":"exercise","acquired":true,"shares":1531,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21785,"source":{"system":"sec-edgar","filing":"0001162194-20-000112","document":"wf-form4_160625649736161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000112/wf-form4_160625649736161.xml","form_type":"4"}},{"id":2968428,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-11-24T22:21:51.000Z","date":"2020-11-20","kind":"exercise","acquired":true,"shares":2598,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20254,"source":{"system":"sec-edgar","filing":"0001162194-20-000112","document":"wf-form4_160625649736161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000112/wf-form4_160625649736161.xml","form_type":"4"}},{"id":3048953,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-08-24T23:20:03.000Z","date":"2020-08-20","kind":"exercise","acquired":false,"shares":1531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":16844,"derivative":{"underlying":"Common Stock","underlying_shares":1531},"source":{"system":"sec-edgar","filing":"0001162194-20-000099","document":"wf-form4_159831114580372.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000099/wf-form4_159831114580372.xml","form_type":"4"}},{"id":3048952,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-08-24T23:20:03.000Z","date":"2020-08-20","kind":"exercise","acquired":false,"shares":2597,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":28576,"derivative":{"underlying":"Common Stock","underlying_shares":2597},"source":{"system":"sec-edgar","filing":"0001162194-20-000099","document":"wf-form4_159831114580372.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000099/wf-form4_159831114580372.xml","form_type":"4"}},{"id":3048951,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-08-24T23:20:03.000Z","date":"2020-08-20","kind":"tax_withholding","acquired":false,"shares":1698,"price":7.91,"value":13431.18,"ownership":{"direct":true},"balance_after":17656,"source":{"system":"sec-edgar","filing":"0001162194-20-000099","document":"wf-form4_159831114580372.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000099/wf-form4_159831114580372.xml","form_type":"4"}},{"id":3048950,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-08-24T23:20:03.000Z","date":"2020-08-20","kind":"exercise","acquired":true,"shares":1531,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19354,"source":{"system":"sec-edgar","filing":"0001162194-20-000099","document":"wf-form4_159831114580372.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000099/wf-form4_159831114580372.xml","form_type":"4"}},{"id":3048949,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-08-24T23:20:03.000Z","date":"2020-08-20","kind":"exercise","acquired":true,"shares":2597,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17823,"source":{"system":"sec-edgar","filing":"0001162194-20-000099","document":"wf-form4_159831114580372.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000099/wf-form4_159831114580372.xml","form_type":"4"}},{"id":3120784,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-06-05T19:55:52.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":6797,"price":4.385,"value":29804.845,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amended Form 4 is being filed solely to report that the number of shares withheld for tax liability upon the vesting of RSU awards represented a disposition of 6,797 shares rather than 7,763 shares, as was reported on the Form 4 filed on May 22, 2020. All other information remains the same."}],"balance_after":15226,"source":{"system":"sec-edgar","filing":"0001162194-20-000068","document":"wf-form4a_159138693503188.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000068/wf-form4a_159138693503188.xml","form_type":"4/A","original_submission_date":"2020-05-22"}},{"id":3135443,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-05-26T13:32:25.000Z","date":"2020-05-23","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vest over three years, with 1/2 of the total number of shares vesting on May 20, 2021 and 1/4 of the total number of shares vesting on each of May 20, 2022 and May 20, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vest over three years, with 1/2 of the total number of shares vesting on May 20, 2021 and 1/4 of the total number of shares vesting on each of May 20, 2022 and May 20, 2023."}],"balance_after":120000,"derivative":{"underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001162194-20-000063","document":"wf-form4_159049992724775.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000063/wf-form4_159049992724775.xml","form_type":"4"}},{"id":3137587,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-05-22T22:29:00.000Z","date":"2020-05-20","kind":"exercise","acquired":false,"shares":6125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":18375,"derivative":{"underlying":"Common Stock","underlying_shares":6125},"source":{"system":"sec-edgar","filing":"0001162194-20-000056","document":"wf-form4_159018652325099.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000056/wf-form4_159018652325099.xml","form_type":"4"}},{"id":3137586,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-05-22T22:29:00.000Z","date":"2020-05-20","kind":"exercise","acquired":false,"shares":10391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter."}],"balance_after":31173,"derivative":{"underlying":"Common Stock","underlying_shares":10391},"source":{"system":"sec-edgar","filing":"0001162194-20-000056","document":"wf-form4_159018652325099.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000056/wf-form4_159018652325099.xml","form_type":"4"}},{"id":3137585,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-22T22:29:00.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":7763,"price":4.385,"value":34040.755,"ownership":{"direct":true},"balance_after":14260,"source":{"system":"sec-edgar","filing":"0001162194-20-000056","document":"wf-form4_159018652325099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000056/wf-form4_159018652325099.xml","form_type":"4"}},{"id":3137584,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-22T22:29:00.000Z","date":"2020-05-20","kind":"exercise","acquired":true,"shares":6125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22023,"source":{"system":"sec-edgar","filing":"0001162194-20-000056","document":"wf-form4_159018652325099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000056/wf-form4_159018652325099.xml","form_type":"4"}},{"id":3137583,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-22T22:29:00.000Z","date":"2020-05-20","kind":"exercise","acquired":true,"shares":10391,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15898,"source":{"system":"sec-edgar","filing":"0001162194-20-000056","document":"wf-form4_159018652325099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000056/wf-form4_159018652325099.xml","form_type":"4"}},{"id":3213772,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-12T22:34:37.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":38250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vest as to 1/4th of the underlying shares on February 20, 2021, and as to an additional 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vest as to 1/4th of the underlying shares on February 20, 2021, and as to an additional 1/16th of the total number of shares each quarter thereafter."}],"balance_after":38250,"derivative":{"underlying":"Common Stock","underlying_shares":38250},"source":{"system":"sec-edgar","filing":"0001162194-20-000023","document":"wf-form4_158405246048719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000023/wf-form4_158405246048719.xml","form_type":"4"}},{"id":3492945,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-06-12T21:32:42.000Z","date":"2019-06-10","kind":"exercise","acquired":false,"shares":10391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 30, 2019, the Reporting Person was granted 10,391 Restricted Stock Units, all of which vested on June 10, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 30, 2019, the Reporting Person was granted 10,391 Restricted Stock Units, all of which vested on June 10, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10391},"source":{"system":"sec-edgar","filing":"0001162194-19-000056","document":"wf-form4_156037514667617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000056/wf-form4_156037514667617.xml","form_type":"4"}},{"id":3492944,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-06-12T21:32:42.000Z","date":"2019-06-10","kind":"tax_withholding","acquired":false,"shares":4884,"price":12.89,"value":62954.76,"ownership":{"direct":true},"balance_after":5507,"source":{"system":"sec-edgar","filing":"0001162194-19-000056","document":"wf-form4_156037514667617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000056/wf-form4_156037514667617.xml","form_type":"4"}},{"id":3492943,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-06-12T21:32:42.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":10391,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10391,"source":{"system":"sec-edgar","filing":"0001162194-19-000056","document":"wf-form4_156037514667617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000056/wf-form4_156037514667617.xml","form_type":"4"}},{"id":3542544,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":130033,"kind":"person","name":"McCracken Colin","position":1,"cik":"0001775380","reported_name":"McCracken Colin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-05-02T21:28:18.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":24500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the Restricted Stock Units vest on May 20, 2020, and the remaining Restricted Stock Units vest in twelve equal quarterly increments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"25% of the Restricted Stock Units vest on May 20, 2020, and the remaining Restricted Stock Units vest in twelve equal quarterly increments thereafter."}],"balance_after":24500,"derivative":{"underlying":"Common Stock","underlying_shares":24500},"source":{"system":"sec-edgar","filing":"0001162194-19-000030","document":"wf-form4_155683248371151.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000030/wf-form4_155683248371151.xml","form_type":"4"}}]}